HARRY GLORIKIAN

Harry Glorikian is a distinguished General Partner at New Ventures Funds, bringing a wealth of experience and strategic vision to the firm's investment activities. In this pivotal role, he is instrumental in shaping the fund's portfolio, identifying companies poised for significant disruption and growth within the health technology and life sciences sectors. His leadership ensures that New Ventures Funds remains at the forefront of investing in the next generation of healthcare innovation.

Glorikian's investment thesis centers on transformative technologies and solutions that address critical unmet needs in healthcare. He actively seeks out companies specializing in digital health, precision medicine, diagnostics, biotechnology, and health data analytics. His keen understanding of market dynamics and technological advancements allows him to pinpoint ventures with strong commercialization potential and the capacity to redefine patient care and outcomes. He is particularly interested in innovations that bridge the gap between scientific discovery and practical application, driving efficiency and effectiveness across the healthcare continuum.

Prior to his role at New Ventures Funds, Harry Glorikian built an impressive career marked by deep engagement in the life sciences and health technology industries. He is widely recognized as a strategic advisor, author, and thought leader. His background includes significant experience in corporate development, strategic planning, and commercialization for both startups and established enterprises. Glorikian has a proven track record of guiding companies through complex market landscapes, helping them to develop robust strategies for growth and market penetration. He is also the author of acclaimed books such as "MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Economy" and "The Future You: How Artificial Intelligence Can Help You Get Healthier, Richer, and Smarter," underscoring his expertise and forward-thinking perspective on the future of health and technology. This diverse experience provides him with a unique vantage point for evaluating investment opportunities and mentoring portfolio companies.

While specific individual investments are often confidential or not publicly detailed, Harry Glorikian's focus at New Ventures Funds is on building a robust portfolio of companies that exemplify innovation and market leadership. He seeks out ventures with strong intellectual property, scalable business models, and visionary leadership teams. His involvement extends beyond capital injection, offering strategic guidance, market access, and operational expertise to help portfolio companies achieve their milestones and accelerate their path to success. The fund's strategy, guided by Glorikian, aims to back companies that are not just financially promising but also have the potential for profound societal impact in healthcare.